信达生物授出合共2.08万份购股权

Core Viewpoint - The company, Sinopharm (01801), announced the granting of stock options to five grantees, including independent non-executive director Dr. Sherwin, under the terms of the 2024 share plan, with a total of 20,800 options to be granted, pending acceptance by the grantees [1] Summary by Relevant Sections - Stock Options Granted - A total of 20,800 stock options will be granted to five grantees [1] - Dr. Sherwin will receive 1,800 stock options as part of this grant [1]